| Tag | Content |
|---|
EnhancerAtlas ID | HS139-15909 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr13:114301540-114302660 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| E2F6 | MA0471.1 | chr13:114302067-114302078 | CTTTCCCGCCC | - | 6.32 | | NR2C2 | MA0504.1 | chr13:114301751-114301766 | TCACCTCTGACCTCT | - | 6.88 | | NR2C2 | MA0504.1 | chr13:114301758-114301773 | TGACCTCTGACCTTC | - | 7.33 | | Nr2f6 | MA0677.1 | chr13:114301758-114301772 | TGACCTCTGACCTT | - | 7.28 | | Rxra | MA0512.2 | chr13:114301758-114301772 | TGACCTCTGACCTT | - | 6.62 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_41872 | chr13:114301246-114302949 | LNCaP |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr13 | 114301674 | 114302571 | | chr13 | 114301802 | 114302224 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH13I113647 | chr13 | 114301216 | 114302896 |
|
Enhancer Sequence | ATAGAGAGAC CCTGCCTCTG AAGAAAGAGT GGGGCTCTGG TGTCCATGGA GAGTCTGGGG 60
AGGGAGGAAG AGGCTAGGGT TCTGAGGGCC TGGAGATGGG GGCTCTGGGT GGCCATGGGA 120
CACGTGGCAG GCGTGTTGGG TTCCAGCTGG GTTGGCTTTG AGAGTCTGGT GGGATGAACC 180
CTCATGGCTC CACCGTCACT TTGAGGTGGT GTCACCTCTG ACCTCTGACC TTCAGCATGG 240
CATGACCTCG CTGAGGTGAC CCTGGTGTCC CACATATCAC CCTGAGTGTT CTTAATACAC 300
AGTCGAGGGC TGTGTTCATT GGACTATTCT GGTGTCACCG CCCACTTCAT TTCTGTGCCT 360
GGCAGCACTT TTACTCCTGG TTGGGAGCAT GACCGCCTCC CAGTTCAGCT TCCTCCTGCG 420
TCCCAAGTGA GCGGGGCGGC TGTCCTCGAG GACTCCGGGC TCACAGCCAA CCTGCTGGCA 480
CGGCTCGAGG ACTCCGGGCT CACAGCCAAC CTGCTGGCAC GGCCGCCCTT TCCCGCCCTG 540
CCTCGGGTGA GCCAAGGACT TGTCTTCTGC TTCCTGGGTT CCTGAAAGAG CTCTCCTCTG 600
ATTTCTCAAA GGCAAAATAA AACTCAGATT TAAGTCTTTG GTGCGTAGCC CCTAATTTCC 660
TTCCCTTTCT CTGAATCCTC ACTGCCCAGC ATGATGGACC GGCCTGGGCT CAGGACCTGA 720
TTCCACAGGC TCCCAGCCCT CCCACAGGTA CCGTGTCTTC TGTGCTGGTG TCGCACCCGC 780
CGGCCACCGC CACCCTGCGT CTTAGACGTC CCGCCGCAGC TGTGTTTCCA CCTCATCTCC 840
AGCTTGAGTG GCAGCCAGCG GCGCCACCTG CACACGAGCC CCCTCCATTC GAGAAGCACA 900
GACTATGAGT GTGGCCACGC GTCCCATGAC GTGAACTCAC GTCTGCGCCG AGACCTTTGC 960
CGGCGGTTTT TTACTGACGG AGTAAGCACT GGAGATGCTT GGTACAGCGT CTTCCATCGG 1020
TAAATTGATT TAGTTAACCT TACAACATAT CTGCAAGGTT TTTAATCTTT CTTCCAAGAC 1080
CGTTTCTCAT GGACTTTTCT GTGTGTCTGT TGGGGGCTGA 1120
|
